Prevention of Type 1 Diabetes from Laboratory to Public Health

References

• Rewers M., Bugawan T. L., Norris J. M., Blair A., Beaty B., Hoffman M. C, et al. Newborn screening for HLA markers associated with IDDM: Diabates Autoimmunity Study in the Young (DAISY). Ditrhetologia 1996; 39: 807–812
   PubMed Web of Science ®Google Scholar
• Ilonen J., Reijonen H., Herva E., Sjoroos M., litia N., Lovgren T., et al. Rapid HLA-DQBI Gcnotyping for Four Alleles in thc Assessment of Risk for IDDM in the Finnish Population. Population. Diabetes Care, 19(8)795–800
   Google Scholar
• Verge C. F., Gianani R. K. M., Jackson R., et al. Prediction of Type I Diabetes in First-Degree Relatives Using a Conibinationoflnsulin, GAD, and ICAS IZbdc'IA-2 Autoantihodies. Diabetes Care, 45: 926–933
   Google Scholar
• Bingley P. J., Bonihcio B., Williams A. J.K., Genovese S., Bottazzo G. F, Gale E. A.M. Prediction oflDDM in the General Population. Strategies Based on Combinations of Autoantibody Markers. Diabetes 1997; 46: 1701–1710
   PubMed Web of Science ®Google Scholar
• Keller R. J., Eisenbarth G. S., Jackson R. A. Insulin prohpylaxis in individuals a t high risk of type I diabetes. Lancet 1993; 341: 927–928
   PubMed Web of Science ®Google Scholar
• Elliott R. B., Pilcher C. C., Stewart A. The use of nicotinamide in the prevention of type 1 diabetes. Ann. N Y Acad. Sci. 1993; 69: 333–341
   Google Scholar
• Akerblom H. K., Paganus A, Teramo K., Saukkonen T., Knip M., Ilonen J., et al. Primary prevention of type 1 diabetes by nutritional intervention. Description of a pilot study. Autoinimunity 1993; 15(suppl)58
   Google Scholar
• Morrison A. S. Screening in chronis Disease. Oxford University Press, New york 1992
   Google Scholar
• Bach J. Predictive Medicinc: From Molecular Genetics t o Prcvcntion. Application t o Insulin-Dependent Diabetes Mellitus. Int. J. Med. Sci 1992; 28: 111–112
   Google Scholar
• British Diabetic Association. Ethical Issues in Research into Prevention of Insulin-dependent Diabetes Mellitiis (IDDM). Diabetic Medicine 1996; 13: 399–400
   Google Scholar
• Nordenfelt L. Prevention and Ethics in Medieinc: The Case of Diabetes Prevention. Journal of Pedeatric Endocrinologu & Metabolism 1996; 9: 381–386
   Google Scholar
• Dahlquist G., Bloni L., Tuvcmo T., Nystrom L., Sandstrom A., Wall S. The Swedish Childhood Diabetes Study rcsults from a 9-year case register and ii I -year casc-referent study indicating that Type I (insulin- dependent) diabetes mellitus is associated with both Type 2 (non-insulin dependent) diabetes mellitus and autoimmune disorders. Diabetelogal 1989; 32: 2–6
   PubMed Web of Science ®Google Scholar
• Cudworth A. G., Woodrow J. C. Evidence for HLA- linked genes in “juvenile” diubctes mellitus. BMJ 1975; 3: 133–135
   PubMed Web of Science ®Google Scholar
• Owerbach D., Nerup J. Restriction fragment length polymorphism of the insulin gcnc in diabetes mellitus. Diabetes 1982; 31: 215–277
   Google Scholar
• Todd J. A., Bell J. I., McDevitt H. O. HLA-DQBgenes conribute to susceptibility and resistance to insulin-dependent diabctcs mcllitus. Nature 1987; 329: 590–604
   Google Scholar
• Horn G., Bugawan T., Long C., Erlich H. Allelic sequence variation of the HLA-DQ loci: relationship to serology and insulin-dependent diabetes susceptibility. Pro Natl. Acda Sci USA 1988; 85: 602–6016
   Google Scholar
• Erlich H., Bugawan T. L., Scharf S., Nepom G. T., Tait B., Griftith R. L. HLA-DQB sequence polymorphism and genetic susceptibility to IDDM. Diabetes 1990; 39: 96–103
   PubMedGoogle Scholar
• Field L. L., Tobias R., Magnu T. A locus on chromosome 15q126 (IDDM3) produces susceptibility to IDDM. Natural Genetics 1994; 8: 189–194
   PubMedGoogle Scholar
• Davies J. L., Kawaguchi Y., Bennett S. T., Copeman J. B., Cordell H. J., Pritchard L. E., et al. A genome-wide search for human type I diabetes susceptibility genes. Nature 1994; 371: 130–136
   PubMed Web of Science ®Google Scholar
• Owerbach D., Gabbay K. H. The HOXDX locus (2q31) is linked to type 1 diabetes: interaction with chromo- somes 6 and 1 I disease susceptibility genes. Diabetes 1995; 44: 132–136
   PubMedGoogle Scholar
• Hashimoto L., Habita C., Beressi J. P., Delepine M., Besse C., Cainbon-Thomsen A., et al. Genetic mapping ofa susceptibility locus for insulin-dependent diabetes mellitus on chromosome 11q. Nature 1994; 371: 161–164
   PubMed Web of Science ®Google Scholar
• Ronningen K. S., Spurkland A., Tait B. D. HLA class iation in insulin-dependent diabetes mellitus among Blacks. Caucasoids and Japanese, K. Tsui, M. Aizawa, T Sasazuki. HLA, Oxford University Press, Oxford 1991; Vol 1: 713–722
   Google Scholar
• Owerbach D., Gabbay K. H. Localization of a type 1 diabetes susceptibility locus to the variable tandem repeat region tlanking the insulin gene. Diabetes 1993; 42: 1708–714
   PubMedGoogle Scholar
• Bergholdt R., Karlsen A., Johannscn J., Hanscn P. M., Dinarello C. A., Nerup J., et al. Characterization of polymorphism of an interleukin 1 receptor type 1 gene (ILIRI) promoter region (P2) and their relation to insulin- dependent diabetes mellitus (IDDM). Cytokinr 1995; 7: 727–F733
   Google Scholar
• Copcman J. B., Cucca F., Heame C M., Cornall R. J., Reed P. W., Ronningen K. S., et al. Linkage disequilibrium mapping of a type 1 diabetes susceptibility gene (IDDM7) to chromosome 2q31-q33. Nature Genetics 1995; 9: 80–85
   Google Scholar
• Luo D., Bui M. M., Muir A., Maclarcn N. K., Thomson G., She J. Affcctcd-sib-pair mapping of a novel susceptibility gene to insulin-dependent diabetes mellitus (IDDM8) on chromosome 6q25-q27. Am. J. Hum. Genet. 1995; 57: 911–919
   PubMedGoogle Scholar
• Field L. L., Tobias R., Thomson G., Plon S. Susceptibility to insulin-dependent diabetes mellitus maps to a locus (IDDMI1) on chromosome 14q24.3-q3L. Genomics 1996; 33: 1–8
   PubMedGoogle Scholar
• Morahan G., Huang D., Tait B. D., Colman P. G., Harrison L. C. Markers on distal chromosome 2q linked to insulin-dependent diabetes mellitus. Science 1996; 272: 1811–1813
   PubMedGoogle Scholar
• Erlich H., Griffith R. L., Bugawan T. L., Ziegler R., Alper C., Eisenbarth G. S. Implication of specific DQB1 alleles in genetic susceptibility and resistance by identification of 1DDM siblings with novel HLADQB1 allele and unusual DR2 and DRI haplotypes. Diabetes 1991; 40: 478–481
   Google Scholar
• Pugliese A., Gianani R., Moromisato R., Awdch Z. L., Alper C. A., Erlich H. A., et al. HLA-DQB1 *0602 is associated with dominant protection from diabetes even among islet cell antibody positive lust degree relatives of patients with insulin-dependent diabetes. Diabetes 1995; 44: 608–613
   PubMedGoogle Scholar
• Olmos P., A'Hem R., Heaton D. A., Millward B. A., Risley D., Pyke D. A., Leslie R. D.G. The significance of the concordance rcatc for type 1 (insulin-dependent) diabetes in identical twins. Diabetologia 1988; 31: 747–750
   PubMed Web of Science ®Google Scholar
• Nistico L., Buzzetti R., Pritchard L. E., Van der Auwera B., Giovannini C, Bosi B., et al. The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with. type 1 diabetes. Human Molecular Genetics 1996; 5: 1075–1080
   PubMed Web of Science ®Google Scholar
• Awata T., Kurihara S., Iitaka M., Takei S., Inouc I., Ishii C., et al. Association of CTLA-4 gene A-G polymor-cphism (IDDM12 locus) with acute-onset and insulin-depleted IDDM as well as autoimmune thyroid disease (Graves' Disease and Hashimoto's Thyroiditis) in the Japanese population. Diabetes 1998; 47: 128–129
   PubMed Web of Science ®Google Scholar
• Halminen M., Veijola R., Reijonen H., Ilonen J., Akerblom H. K., Knip M., et al. Effect of polymorphism in the insulin gene region on IDDM susceptibility and insulin secretion. Journal of Clinical Investigation 1996; 26: 847–852
   Google Scholar
• Todd J. A., Farrall M. Panning for gold: genome-wide scanning for linkage in type I diabetes. Human Molecular Genetics 1996; 5: 1443–1448
   PubMed Web of Science ®Google Scholar
• Kawaguchi Y., Ikcgami H., Shen G. Q., Nakagavva Y., Fujisavva T., Hamada Y., et al. Insulin gene region contributes to genetic susceptibility to, but may to low incidence of, Insulin-Dependent Diabetes Mellitus in Japanese. Biochemical anil Biophysical Research Communications 1997; 233: 283–287
   Google Scholar
• Matron M. P., Raffel L. J., Garchon H. J, Jacob C O., Seffano-Rios M., Larrad Martinez M.T., et al. Insulin-dependent diabetes mellitus (IDDM) is associated with CTL4 polymorphisms in multiple ethnic groups. Human Molecular Genetics 1997; 6: 1275–1282
   Google Scholar
• Undelien D. E., Friede T., Rammensec H. G., Joner G., Dahl-Jorgensen K., Sovik O., et al. HLA-encoded genetic predisposition in IDDM DR4 subtypes may be associated with different degrees of protection. Diabetes 1997; 46: 143–149
   Google Scholar
• Nejentsev S., Reijonen H., Adojaan B., Kovalchuk L., Sochnevs A., Schwartz E. I., et al. The effect of HLA-B allele on the IDDM risk defined by DRB1 *04 subtypes and DOB 1*0302. Diabetes 1997; 46: 1888–1892
   Google Scholar
• Harfouch-Hammoud E., Timsit J., Boitard C, Bach J. F., Caillat-Zucman S. Contribution of DRB1*04 variants to predisposition to or protection from insulin dependent diabetes mellitus is independent of DQ. Journal of Autoimmunity 1996; 9: 411–414
   Google Scholar
• Matsumoto C, Awata T., Iwamoto Y., Kuzuya T., Saito T., Kanazawa Y. Lack of association of the insulin gene region with Type 1 (insulin-dependent) diabetes mellitus in Japanese subjects. Diabetologia 1994; 37: 210–213
   PubMedGoogle Scholar
• Undlien D. E., Hamaguchi K., Kimura A., Tuomilehto B., Swai A. B.M., McLarty D. G., et al. IDDM susceptibility associated with polymorphisms in the insulin gene region; A study of blacks, Caucasians and orientals. Diabetologia 1994; 37: 745–749
   PubMed Web of Science ®Google Scholar
• Undlien D. E., Bennett S T., Todd J. A., Akselscn H. F., Ikaheimo I., Reijonen H., et al. Insulin gene region-encoded susceptibility to IDDM maps upstream of the insulin gene. Diabetes 1995; 44: 620–625
   PubMedGoogle Scholar
• Van Der Auwera B., Schuit F., Lyaruu I., Falomi A., Scanhold S., Vandewalle, et al. Genetic Susceptibility for Insulin-Dependent Diabetes Mellitus in Caucasians Revisited: The Importance of Diabetes Registries in Disclosing Interactions between HLA-DQ- and Insulin Gene-Linked Risk. Journal of Clinical Endocrinology and Metabolism 1995; 80(9)2567–2573
   Google Scholar
• Atkinson M. A., Maclarcn N. K. Islet cell autoantigens in insulin-dependent diabetes. J. Clin. Invest. 1993; 92: 1608–1616
   PubMed Web of Science ®Google Scholar
• Guaita G., Mulas M. F., Saba M., Pelligra I., Cocco S., Cossu B., et al. The Sardinian newborn IDDM (SNI) study. Prevelenee of ICA in a large cohort of 4755 newly born children in Sardinia. Autoimmunity 1995; 21: 38–39
   Google Scholar
• Roll U., Christie M. R., Fuchtenbusch M., Payton M. A., Hawkes C. J., Ziegler A. G. The German multiccntcr BABY-D1AB study: detection of humoral immune responses to islet antigens in early childhood. Diabetes 1996; 45: 967–973
   PubMedGoogle Scholar
• Arvilommi P., Hakala R., Kupila A., Muona P., Simell T., Torma M., et al. ICA-Positive children in the DIPP trial. Diabetes Abstract Book SSlh Scientific Sessions. June, 1998; A227
   Google Scholar
• Yu M. S., Mitchell C M., Butler-Simon N., Groshek M., Follensbee D., Erlich I I, et al. The Impact on Maternal Parenting Stress of Receipt of Genetic Information Regarding Risk of Diabetes in Newborns. 1997, Unpublished
   Google Scholar
• Frost N. Genetic Diagnosis and Treatment. AJDC 1993; 147: 1190–1195
   Google Scholar
• Wingrove K., Hagerman R., Barton P. L., Norris I. Experiences and Attitudes Concerning Genetic Testing and Insurance in a Colorado Population: A Survey of Families with Fragile X Syndrome. 1996, Unpublished
   Google Scholar
• Atkinson M. A., Maclaren N. K. The pathogenesis of insulin-dependent diabetes mellitus. N. Engl. J. Med. 1993; 331: 142–1436
   Google Scholar
• Bach J. F. Insulin-dependent diabetes mellitus as an autoimmune disease. Endocr. Rev. 1994; 15: 516–541
   PubMed Web of Science ®Google Scholar
• Cudworth A. G., Woodrow J. C. Genetic susceptibility in diabetes mellitus: Analysis of the HLA association. BMJ 1976; 2: 846
   Google Scholar
• Sperling M. A. Diabetes mellitus, M. A. Sperling. Pediatric Endocrinology, W.B. Saunders, Philadelphia 1996; 229–263
   Google Scholar
• Eisenbarth G. Prediction and Prevention Strategies in Type I Diabetes. The Mount Sinai Journal of Medicine 1991; 58: 274–279
   Google Scholar
• Verge C. F., Eisenbarth G. C. Stragegies for Preventing Type 1 Diabetes Mellitus. West. J. Med. 1996; 164: 249–255
   Google Scholar
• Sorenson J. R., Levy H. L., Mangione T. W., Sepe S. J. Parental response to repeat testing of infants with ‘false positive’ results in a newborn screening program. Pediatries 1984; 73: 183–187
   Google Scholar
• Johnson S. B., Tercyak K. P. Psychological Impact of Islet Cell Antibody Screeing for IDDM on Children, Adults and their Famiy Members. Diabetes Care 1995; 18: 1370–1372
   Google Scholar
• Dittler J., Seidel D., Schenkcr M., Zieglcr A. G. GADlA2-combi determination as first-line screening for improved prediction of type 1 diabetes in relatives. Diabetes 1998; 47: 592–597
   Google Scholar
• Yu L., Simone E., Eisenbarth G. S. Modification to combined GAD65/ICA512 radioassay for general population screening. Abstract presented at the American Diabetes Association 31 st Research Symposium on the Prevention of Type 1 Diabetes in the General Population, Estes Park, September, 1996
   Google Scholar
• Vardi P., Crisa L., Jackson R. A. Predictive calue of intravenous glucose tolerance test insulin secretion less than or greater than the first percentile in islet cell antibody positive relatives of type 1 (insulin-dependent) diabetic patients. Diabeto/ogia 1991; 34: 93–102
   PubMed Web of Science ®Google Scholar
• Jackson R. A. Dual parameter linear model for prediction of onset of type 1 diabetes in islet cell antibody positive relatives. Clin. Res. 1988; 36: 484A
   Google Scholar
• Vlahos W. D., Seemayer T. A., Yale J. F. Diabetes prevention in BB rates by inhibition of endogenous insulin secretion. Metabolism 1991; 40: 825–829
   PubMed Web of Science ®Google Scholar
• Atkinson M. A., Maclaren N. K., Luchetta R. Insulitis and insulin dependent diabetes in NOD mice reduced by prophylactic insulin therapy. Diabetes 1990; 39: 933–937
   PubMed Web of Science ®Google Scholar
• Gladstone P., Nepon G. T. The prevention of IDDM: injeting insulin into the cytokine network. Diabetes 1995; 44: 859–862
   Google Scholar
• Aaen K., Rygard J., Josenson K., Brogren C. H., Horn T., Buschard K. Dependence of antigen expression on functional state of cells. Diabetes 1990; 39: 697–701
   PubMed Web of Science ®Google Scholar
• Bowman M. A., Campbell L., Darrow B. L. Immunological and metabolic effects of prophylactic insulin therapy in the NOD-scid/scid adoptive transfer model of IDDM. Diabetes 1996; 45: 205–208
   PubMed Web of Science ®Google Scholar
• Skyler J. Presented on behalf of DPT1 at ADA meeting. 1997, Unpublished
   Google Scholar
• Honeyman M., Wasserfall C, Nerup J., Rossini A. Prediction and prevention of IDDM. Diabetotogia 1997; 40: 58–61
   Google Scholar
• Bingley P. February, 1998, Personal communication
   Google Scholar
• Elliott R. B., Chase H. P. Prevention or delay of type 1 (insulin-dependent) diabetes in children using nicotinamide. Diabetologia 1991; 34: 362–366
   PubMed Web of Science ®Google Scholar
• Elliott R. B., Pilcher Fergusson D.M., Stewart A. W. A population based strategy to prevent insulin-dependent diabetes using nicotinamide. J. Pediatr. Endocrinol. Metab. 1996; 9: 501–509
   PubMed Web of Science ®Google Scholar
• Zhang I., Davidson L., Eisenbarth G., Weiner H. L. Suppression of diabetes in non-obese diabetic mice by oral administration of porcine insulin. Proe. Natl. Acad. Sci. 1991; 88: 10252–10256
   PubMed Web of Science ®Google Scholar
• Elliott J. F., Qin H. Y., Bhatti S., Smith D. K., Singh R. K., Dillion T., et al. Immunization with thelargerisoform of mouse glutamic acid decarboxylase (GAD67) prevents autoimmune diabetes in NOD mice. Diabetes 1994; 43: 1494–1499
   PubMed Web of Science ®Google Scholar
• Pozzilli P. Prevention of insulin-dependent diabetes mellitus 1998. December, 1997, Submitted for publication
   Google Scholar
• Leslie R. D.G., Elliott R. B. Early environmental events as a cause of IDDM: Evidence and implications. Diabetes 1994; 43: 843–850
   PubMed Web of Science ®Google Scholar
• Gerstein H. C. Cow's milk exposure and type 1 diabetes mellitus. A critical overview of the clinical literature. Diabetes Care 1994; 17: 13–19
   PubMed Web of Science ®Google Scholar
• Norris J. M., Scott F. W. A meta-analysis of infant diet and insulin-dependent diabetes mellitus: do biases play a role?. Epidemiology 1996; 7: 87–92
   PubMed Web of Science ®Google Scholar
• Norris J. M., Beaty B., Kligensmith G., Liping Yu, Hoffman M., Chase H. P., et al. Lack of association between early exposure to cow's milk protein and beta-cell autoimmunity. Diabetes Autoimmunity Study in the Young (DAISY). JAMA 1996; 276: 609–614
   PubMed Web of Science ®Google Scholar
• Bodington M., McNally P. G., Burden A. C. Cow's milk and type 1 childhood diabetes: no increase in risk. Diabetic Med 1994; 11: 662–665
   Google Scholar
• Perez-Bravo F., Carrasco B., Gutierrez-Lopez M. D., Martinez M. T., Lopez G, Garcia dc los Rios M. Genetic predisposition and cnviornmental factors leading to the development of insulin-dependent diabetes mellitus in Chilean children. Journal of Molecular Medicine 1996; 74: 105–109
   Google Scholar
• Vaarala O., Klemeti P., Savilahti E., Reijonen H., Ilonen J., Akerblom H. K. Cellular immune response to cow's milk B-laetoglobulin in patients with newly diagnosed IDDM. Diabetes 1996; 45: 178–182
   PubMed Web of Science ®Google Scholar
• Meloni T., Marinaro A. M., Mannazzu M. C., Ogana A., La Vecchia C, Negro B., et al. IDDM and early infant feeding; Sardinian case-control study. Diabetes Care 1997; 20: 340–342
   Google Scholar
• Martikainen A., Saukkonen T., Kulmala P. K., Reijonen H., Ilonen Teramo K., et al. Disease-associated antibodies in offspring of mothers with IDDM. Diabetes 1996; 45: 1706–1710
   PubMedGoogle Scholar
• Levy-Marchal C, Karjalainen J., Dubois F., Karges W., Czernichow P., Dosch H. M. Antibodies against bovine albumin and other diabetes markers in French children. Diabetes Care 1995; 18: 1089–1094
   Google Scholar
• Karjalainen J., Martin J. M., Knip M., Ilonen J., Robinson B. H., Savilahti E., et al. A bovine albumin peptide as a possible trigger of insulin-dependent diabetes mellitus. New England Journal of Medicine 1992; 327: 302–307
   PubMed Web of Science ®Google Scholar
• Cavallo M. G., Monetini L., Barone F., Pozzilli P. Cell mediated immune response to beta eaesin in recent onset insulin-dependent diabetes: implications for disease pathogenesis. Lancet 1996; 348: 926–928
   PubMed Web of Science ®Google Scholar
• Atkinson M. A., Bowman M. A., Kao K. J., Campbell L., Dush P. J., Shah S. C., et al. Laco of immune responsiveness to bovine serum albumin in insulin dependent diabetes. New England Journal of Medicine 1993; 329: 1853–1858
   PubMed Web of Science ®Google Scholar
• Daniel D., Wcgnann D. R. Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9–23). Proc. Natl. Acad. Sci. 1996; 93: 956–960
   PubMed Web of Science ®Google Scholar
• Bowman M. A., Leiter E. H., Atkinson M. A. Prevention of diabetes in the NOD mouse: implications for theraputic intervention in human disease. Immunology Today 1994; 15: 115–121
   PubMedGoogle Scholar